Addex Therapeutics (ADXN) News Today $8.00 +0.05 (+0.63%) As of 01/17/2025 03:58 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Addex Therapeutics Ltd (NASDAQ:ADXN) Sees Significant Drop in Short InterestJanuary 16, 2025 | americanbankingnews.comAddex to Present at the 2025 Swiss Equities Baader ConferenceJanuary 8, 2025 | globenewswire.comAddex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call Highlights: Strategic Partnerships and ...November 23, 2024 | gurufocus.comQ3 2024 Addex Therapeutics Ltd Earnings Call TranscriptNovember 23, 2024 | gurufocus.comQ3 2024 Addex Therapeutics Ltd Earnings Call TranscriptNovember 22, 2024 | gurufocus.comAddex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call TranscriptNovember 22, 2024 | seekingalpha.comAddex Therapeutics Q3 Net Loss Narrows, Income DropsNovember 22, 2024 | markets.businessinsider.comAddex Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNovember 22, 2024 | globenewswire.comAddex Therapeutics Q3 2024 Earnings Preview: What Investors Need to KnowNovember 21, 2024 | theglobeandmail.comAddex Therapeutics: Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024November 12, 2024 | finanznachrichten.deAddex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024November 11, 2024 | globenewswire.com3 Growth Companies With High Insider Ownership On The SIX Swiss ExchangeOctober 12, 2024 | finance.yahoo.comBuy Rating Affirmed for Addex Therapeutics Amid Promising Clinical Developments and Strategic Neurosterix SpinoutOctober 3, 2024 | markets.businessinsider.comAddex Therapeutics Ltd (ADXN) Q2 2024 Earnings Call Transcript Highlights: Key Financials and ...October 1, 2024 | finance.yahoo.comAddex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate UpdateSeptember 30, 2024 | globenewswire.comAddex Therapeutics: Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net ProfitSeptember 20, 2024 | finanznachrichten.deAddex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net ProfitSeptember 19, 2024 | globenewswire.comAddex to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 4, 2024 | globenewswire.comPositive Outlook for Addex Therapeutics: Significant Collaboration Payments and Promising Pipeline Drive Buy RatingAugust 28, 2024 | markets.businessinsider.comClinical Collaboration Ignites Addex Therapeutics (ADXN) Stock RallyAugust 28, 2024 | msn.comCrude Oil Dips; Addex Therapeutics Shares Spike HigherAugust 27, 2024 | benzinga.comAddex Therapeutics: Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research CollaborationAugust 27, 2024 | finanznachrichten.deJohnson Johnson-Partner Addex Therapeutics Selects Investigational Compound For Substance Use DisorderAugust 27, 2024 | finance.yahoo.comAddex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research CollaborationAugust 27, 2024 | globenewswire.comAddex Therapeutics Insider Ups Holding By 71% During YearAugust 19, 2024 | finance.yahoo.comCK Life Sciences Int'l., (Holdings) Inc. (LSI.F)August 15, 2024 | finance.yahoo.comBuy Rating Affirmed for Addex Therapeutics Amid Strategic Spinout and Promising Drug PipelineJuly 31, 2024 | markets.businessinsider.comAddex Therapeutics Ltd (APE1.MU)July 24, 2024 | sg.finance.yahoo.comAddex Therapeutics: Addex's Partner Discontinues ADX71149 development in EpilepsyJuly 22, 2024 | finanznachrichten.deAddex Therapeutics: Addex's Partner Janssen Pharma Discontinues ADX71149 development in EpilepsyJuly 22, 2024 | finanznachrichten.deAddex's Partner Discontinues ADX71149 development in EpilepsyJuly 22, 2024 | globenewswire.comAddex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International Cough Symposium (13th LICS)July 15, 2024 | globenewswire.comAddex To Present at the Thirteenth London International Cough Symposium (13th LICS)July 12, 2024 | globenewswire.comAddex Shareholders Approve All Resolutions at Annual General MeetingJuly 1, 2024 | globenewswire.comADXN Stock Earnings: Addex Therapeutics Reported Results for Q1 2024June 6, 2024 | investorplace.comAddex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate UpdateJune 6, 2024 | globenewswire.comAddex Convenes Annual General Meeting 2024June 5, 2024 | globenewswire.comAddex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024May 31, 2024 | globenewswire.comAddex to Present at Bio€quity Europe 2024May 8, 2024 | globenewswire.comAddex Therapeutics Ltd ADR ADXNMay 8, 2024 | morningstar.comTech Rally Subsides as US Equity Futures Waver Pre-BellApril 29, 2024 | msn.comAddex stock plunges 50% on failed study for epilepsy drugApril 29, 2024 | msn.comTrading was temporarily halted for "ADXN" at 10:04 AM with a stated reason of "LULD pause."April 29, 2024 | marketbeat.comAddex Therapeutics: Addex Provides Update on ADX71149 Phase 2 Epilepsy StudyApril 29, 2024 | finanznachrichten.deAddex Provides Update on ADX71149 Phase 2 Epilepsy StudyApril 29, 2024 | globenewswire.comAddex to Present at the Swiss Biotech Day 2024April 19, 2024 | globenewswire.comADXN Stock Earnings: Addex Therapeutics Reported Results for Q4 2023April 18, 2024 | investorplace.comAddex Therapeutics GAAP EPS of -CHF 0.14, revenue of CHF 1.65MApril 18, 2024 | seekingalpha.comAddex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate UpdateApril 18, 2024 | globenewswire.comAddex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024April 11, 2024 | globenewswire.com Get Addex Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ADXN and its competitors with MarketBeat's FREE daily newsletter. Email Address ADXN Media Mentions By Week ADXN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADXN News Sentiment▼0.380.49▲Average Medical News Sentiment ADXN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADXN Articles This Week▼11▲ADXN Articles Average Week Get Addex Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ADXN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies KALA BIO News Lexaria Bioscience News Akari Therapeutics News Lisata Therapeutics News Cadrenal Therapeutics News Verrica Pharmaceuticals News Chemomab Therapeutics News Omega Therapeutics News Marinus Pharmaceuticals News CEL-SCI News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ADXN) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Addex Therapeutics Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Addex Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
